Clinical Trial Update: A Study to Evaluate the Lipid Regulating Effects of 1-Methylnicotinamide (1-MNA) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial updates the lipid-regulating effects of 1-Methylnicotinamide (1-MNA) in hypertriglyceridemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• 1-Methylnicotinamide (1-Methylnicotinamide)

Snippet

Sponsor: Montreal Heart Institute | Conditions: Hypertriglyceridemia | Phase 2, Phase 3 | Status: COMPLETED